Credit Suisse analyst Brian Russo upgraded Sirius XM Holdings to Outperform from Neutral with a $7 price target. The stock closed Friday at $5.31. The stock decline has brought an attractive risk/reward opportunity, Russo tells investors in a research note. Consensus estimates for EBITDA and free cash flow have fallen to roughly in-line with the company's 2019 guidance, which is rare given management's long track record of beating their outlook, adds the analyst. Russo now sees upside to estimates given Sirius XM's "solid" operating trends and "powerful" stock buyback.

Latest data shows the largest indicative borrow rate increases among liquid option names include: Aurora Cannabis (ACB) 83.87% +1.16, B Riley Principal Merger Corp II (EOSE) 11.55% +1.08, ALTC Acquistion Corp (ALCC) 5.74% +1.02, VinFast Auto LTD (VFS) 124.46% +0.87, Sirius XM (SIRI) 13.95% +0.56, Medical Properties Trust (MPW) 10.91% +0.41, Spring Valley Acquisition Corp (SMR) 17.81% +0.38, Sellas Life Sciences (SLS) 69.10% +0.37, Valkyrie Bitcoin Miners ETF (WGMI) 2.31% +0.33, and Cassava Sciences (SAVA) 19.19% +0.33.